FB
ALXN

Fulton Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Fulton Bank’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,834
Closed -$337K – 545
2021
Q2 		$337K Sell
1,834
-9,034
-83% -$1.55M 0.02% 375
2021
Q1 		$1.66M Sell
10,868
-979
-8% -$151K 0.08% 169
2020
Q4 		$1.85M Buy
11,847
+210
+2% +$27K 0.1% 152
2020
Q3 		$1.33M Sell
11,637
-1,295
-10% -$140K 0.08% 166
2020
Q2 		$1.45M Sell
12,932
-132
-1% -$14K 0.1% 160
2020
Q1 		$1.17M Buy
13,064
+1,783
+16% +$175K 0.09% 165
2019
Q4 		$1.22M Buy
11,281
+3,454
+44% +$369K 0.08% 185
2019
Q3 		$767K Buy
+7,827
New +$882K 0.05% 218

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Fulton Bank's ALXN Position: Q3 2021 in Review

Fulton Bank sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 1,834 shares — an estimated $337K sold.

Fulton Bank first reported a position in ALXN in Q3 2019 and held it in 8 quarters. The position peaked at $1.85M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Fulton Bank reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Fulton Bank sold 1,834 Alexion Pharmaceuticals shares in Q3 2021, an estimated $337K.
  • Fulton Bank first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 8 quarters.
  • Fulton Bank's Alexion Pharmaceuticals position peaked at $1.85M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Fulton Bank's 13F filing for Q3 2021, filed 5 Oct 2021.